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A REVIEW OF PSYCHOPHARMACOLOGIC DRUGS
ROBERT R . SCHOPBACH, M.D.*

Almost every week a new drug is marketed which is aimed at altering psychic
behavior. This review is an attempt to group and to clarify the actions of this growing
multitude. In many cases the actions of members of a group are essentially identical
and the choice will be determined by which sales representative visited you or by a
chance initial favorable response to one of them. There are however some advantages
which may prove helpful in solving specific problems. The following is a general
outline of current drugs, their indications, dosage, and side effects.
I.

Psychic inhibitors
A.

Sedatives (in moderate doses) and Hypnotics (in larger doses) — These
reduce the activity of the cortex primarily although in large doses the
functions of other portions of the nervous system may be reduced. No
effect on delusions or other psychotic processes.
1.

Barbiturates — Although this is a large group, many doctors do not
take advantage of their varied durations of action. Short acting compounds given to older persons may produce delirium whereas the
longer acting ones may not. A person having trouble falling asleep
will benefit more from a short acting drug which will not impair his
awareness upon arising while the person who can not remain asleep
may require a longer acting compound. I f given for pain without
analgetics in addition, these may produce delirium. The prolonged
adminstration of as little as 4 grains of sodium amytal daily may
produce habituation with a withdrawal syndrome including convulsions.

2.

Bromides — skin reactions and toxic psychoses may result.

3.

Chloral hydrate — usually well tolerated by even the aged. 0.5-1.0 gm.
available in capsules and liquid.

4.

Paraldehyde — an ideal potent drug except for taste and odor. 5-10 cc.
This objection can be reduced by taking in iced fruit juice. Paral
(Fellows) 1.0 gm. capsules are also available.

5.

Doriden (Ciba) 250 mg t.i.d. for sedation, 500 mgm, h.s. for sleep.

6.

Noludar (Roche) 50 mg for sedation, 200 mg for sleep. Similar to
pentobarbital.

7.

Carbital (Parke-Davis) 1 capsule for sleep.

8.

Valmid (Lilly) 500 mg; very rapid short action; for sleep.

9.

Lotusate (Winthrop-Stearns) 50 mg t.i.d.

10.

Placidyl (Abbott) 100 mg t.i.d. for sedation; 500 mg for sleep.

11.

Quiactin (Merrell) 400 mg q.i.d. for sedation.

12.

Softran (Stuart) 50 mgm t.i.d.

13.
14.

Suvren (Ayerst) 100 mg t.i.d.; also spasmolytic.
Scopolamine.

"Division of Psychiatry.
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B.

15.

Narcotics — use only when severe pain is a factor.

16.

Meprobamate 400 mg q.i.d. This is basically a sedative although it
also has a definite effect upon the peripheral neuromuscular system
producing muscle relaxation; actually this may be its primary action.
Conditioned responses are blocked only at neurotoxic levels. Like
barbiturates it is habituating and withdrawal syndromes may follow
its discontinuance. Aplastic anemia and three deaths have been reported.
It is a poor drug for producing sleep but is of special benefit in
conditions where muscle relaxation as well as sedation is desired as
in wry neck, tension headache, neuromyositis, etc.

Neuroleptics — these block conditioned and avoidance responses and are
especially good for reducing aggressivity. In moderate doses cortical activity
and peripheral actions are not impaired but persons working around moving
machinery or driving should be cautioned and watched carefully initially as
some persons are affected. Barbiturates and alcohol are potentiated. This
must be considered in anaesthesia and in the patient who might have his
usual few drinks and attempt to drive.
1.

Rauwolfia compounds — these act by liberating serotonin and biologically active catecholamines from various body cells whereupon they
are destroyed by oxidases, especially monoamine oxidase. Adenosine
triphosphate levels are also altered. These drugs act more slowly than
phenothiazines and are more likely to produce parkinsonism, asthenia,
depressions so are not widely used now.

2.

Phenothiazines — these may act by interfering with the action of
nor-epinephrine in the brain.

Trade name
Compazine
Dartal
Mellaril
Pacatal
Permitil
Prolixin
Sparine
Stelazine
Tentone
Thorazine
Trilafon
Vesprin

Manufacturer
SKF
Searle
Sandoz
Warner
White
Squibb
Wyeth
SKF
Lederle
SKF
Schering
Squibb

Chemical name
prochlorperazine
thiopropazate
thiodiazine
mepazine
triflurmethyl phenazine
fluphenazine
promazine
trifluoperazine
methoxypromazine
chlorpromazine
perphenazine
triflupromazine

Dose
10 mg
10
25
50
0.25
1
50
2
25
25
4
10

Indications — Hyperactivity, panic, agitation, assaultiveness,
destmctiveness, obsessions and compulsions (but to a lesser degree),
acting out especially when it is interfering with psychotherapy, and
to reduce the awareness of pain when symptoms are physically painful.
Schizophrenia may possibly be associated with excessive transamination
in which case rauwolfia and phenothiazines would be chemically indicated. In the acute forms without paranoia or profound dissociation
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phenothiazines produce a cure of better quality and duration than does
insulin coma. The paranoid type does better on phenothiazines than
with either EST or insulin. The catatonic form does better with EST.
The chronic form does as well on phenothiazines as any other therapy.
Improvements seen with phenothiazines are of better quality than
spontaneous cures. Initially some patients feel a void where the "voices"
had counselled or governed them and experience difficulty at first in
making their own decisions. Catatonic stupor and excitement are
usually relieved. "Word salad" disappears and meaningful speech
becomes possible.
The apperception of incoming stimuli both from within and from
the environment is apparently reduced. Defenses and inhibitions may
then be reduced as that against which they were defending is perceived
as less threatening. Perhaps because the energies of instinctual drives
is lessened the superego is not as rigid in denouncing them. Secondary
delusions, obsessions, and compulsions become less imperative. The
patient begins to feel less fearsome and less fearful both of himself and
of others. Innate energies are released for further reorganization and
reality testing and the personality undergoes progressive psychologic
changes on the basis of more successful living. This may be hastened
by psychotherapy. As the patient's behavior toward those about him
improves, they will become more friendly toward him thus creating
an improved and more gratifying environment.
In neurotics the dulling and stabilization of the autonomic
system's functions reduces the physical complaints so that the patient
can better see beyond them and concentrate on psychotherapy. The
phenothiazines are often helpful in this without depressing cortical
activity as much as the sedative group. Vague, generally uncomfortable,
free-floating anxiety is not particularly relieved by any drug. The
administration of any drug tends to increase the positive transference
toward the doctor. This plus the attitude of the dispensing physician
may produce powerful placebo effects of which you must be constantly
cognizant. I f the patient has no insight into the fact that psychologic
factors are creating the symptoms and if you relieve the symptoms with
drugs, it is possible that he may no longer desire to do anything about
the cause but merely continue to demand the dmgs. This is usually
undesirable although in some individuals psychotherapy may not be
feasible and also spontaneous cures under drugs alone are not
unknown. Pathogenic drives are more readily affected than normal
activities. However, if, as in character disorders, no such sharp
distinction exists, an effective dose will likewise obtund normal functioning. In these only long term psychotherapy is indicated.
Complications with phenothiazines — The incidence of side effects
is roughly proportional to the dosage but some individuals may react
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to even small doses. These reactions usually appear within the first two
weeks so the patient should be observed carefully during that period.
It is probably good practice to check the white blood count at the end
of that period. The most common complication is the development of
a Parkinson-like syndrome. Both this and akathisia respond well to a
reduction in the dose plus one of the anti-Parkinson drugs (Artane,
Cogentin, Kemadrin). Akathisia consists of motor restlessness, inner
sensations of jitteriness, and restless feelings in the legs. This is difficult
to distinguish from the symptom for which you may be giving the drug
and, unles you are alert for its occurence, you may increase the dosage
and only aggravate the situation. A l l of the phenothiazines may cause
a toxic hepatitis with jaundice although this is less frequent in the
newer compounds. Skin rashes may occur not only from consuming
the drug but from handling it especially the injectionable solutions.
Other side effects may be dry mouth, drowsiness, hypotension, dyskinetic spasms and movements, fibrillary twitchings, and agranulocytosis. Should any hypotension be prolonged intravenous nor-adrenalin
is indicated.
Symptoms in psychiatry are the patient's deviant expressions of his
inability to face himself and his inner impulses. The alteration or
control of these .symptoms by a drug may be experienced by the patient
as either beneficial or undesirable. This is determined to a large degree
by the attitudes of the doctors, nurses, and others around him. Some
may see the doctor, hospital, and the medications as part and parcel
of a threatening situation against which they must muster every defense.
The administration of drugs may thus be followed by more disturbed
paradoxical behavior sometimes similar to akathisia; this however is
not relieved by anti-parkinson drugs.
3.

Diphenyl methane derivatives.
a.

Hydroxyzines
(1) Atarax (Roerig) 25 mg t.i.d.
(2) Vistaril (Pfizer) 25 mg t.i.d.

b.

Benactyzine of Suavitil (Merck) 1 mg t.i.d.

c.

Azacyclonol of Frenquel (Merrell) 100 mg t.i.d.
These compounds are closely related to antihistamines and
perhaps act by blocking some of the actions of serotonin. They are
considerably weaker than phenothiazines but have somewhat
similar indications.

II.

Psychic activators
A.

Stimulants — enhance conditioned avoidance behavior and arousal. These
may be helpful for moderate asthenia, tiredness, or depression but a tolerance
tends to develop quickly.
1.

Amphetamines - potent
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B.

a.
b.
c.
d.
e.

III.

2.

Meratran (pipradrol) Merrell 2.5 mg b.i.d. - milder

3.

Ritalin (phenidylate) Ciba 5 mg t.i.d. - milder

Energizers
1. Hydrazines — The current theory is that these act by preventing the
destruction of serotonin and catecholamines by mono-amine oxidase
however there are some doubts now that this completely and accurately
explains the action. Since depression is postulated to be related to
excessive oxidative deamination, this group of drugs was tested for
anti-depressive action and has proven to be helpful in many cases. The
action however is not dramatic and may require as long as a month.
If the depression is not severe or if EST is contraindicated in
severe depressions, these dmgs are useful. In severe depressions,
however, the danger of suicide often makes the more rapid treatment
by EST preferred. Hypotension, constipation, jitteriness, and jaundice
may occur.
Marsilid
Marplan
Nardil
Niamid
Catron

iproniazid
benzyl hydrazine
phenethyl hydrazine
a complex hydrazine
phenylisoproply hydrazine

Roche
Roche
Warner
Pfizer
Lakeside

25-50 mg tid
10 mg tid
15 mg tid
25 mg tid
3 mg tid

2.

Tofranil - dibenzephine - Geigy 25-50 mg q.i.d.
The action of this compound is not understood but empirically it has
proven useful in combating depressions. Excessive sweating, dry mouth,
and jitteriness may occur.

3.

Deaner - diethylamino ethanol Riker 50 mg t.i.d.
The action of this drug is much weaker than those above and is based
upon the postulated conversion of the drug into acetyl choline which
passes through the blood-brain barrier.

Psychomimetics or Dysleptics
This group consists of a number of compounds containing an indole nucleus such
as lysergic acid diethylamide (LSD) and mescaline. Their effect may be through
interfering with serotonin metabolism or other brain metabolic functions especially
with carbohydrates. Their use thus far has been limited to experimental studies
of the psychic and biochemical changes induced.

IV.

Placebos
This group of "drugs" is probably the most neglected of all although repeated
studies have shown that 25-35% of subjects reported definite improvement; some
even developed remarkable "side effects". I f the physician is able to afford his
patient relief without introducing any potent and possibly harmful dmg into his
system, is he not to be more highly commended? This also helps prevent overenthusiastic claims for a drug when the favorable results are more closely
related to the doctor's enthusiastic approach to the patient.
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